PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 14, 2026Lara D. Veeken0 citations

Greyscale, color Doppler, and oscillometric macroangiopathy indices in patients with autoinflammatory syndromes: the INFLAMMACARD cohort

View Full Paper
KTK. TriantafylliasAMAnna MandelGKGeorgeD. Kitas

Key Points

  • To evaluate the association of novel angiopathy indices with disease and patient characteristics in autoinflammatory syndromes.
  • Utilized colour Doppler ultrasound to assess arterial compliance markers in patients and controls.
  • Measured carotid intima-media-thickness and plaque presence using greyscale ultrasound.
  • Evaluated aortic stiffness through carotid-femoral-pulse-wave-velocity.
  • Patients with autoinflammatory syndromes displayed increased Pulsatility-Index compared to controls.
  • Aortic stiffness was notably higher in untreated patients, indicating significant vascular abnormalities.
  • Predictors for stiffness included age, systolic arterial pressure, and lymphadenopathy.

Abstract

Abstract Objectives To evaluate for the first time a combination of novel colour Doppler ultrasound (CDUS), greyscale (GSUS), and oscillometric indices of angiopathy in patients with autoinflammatory syndromes (AIS). Furthermore, to explore the associations between these markers and patient- and disease-related characteristics, as well as traditional cardiovascular (CV) risk factors. Methods CDUS was used to assess arterial compliance markers, such as Resistance-Index (RI), Pulsatility-Index (PI), and flow-velocity-integral (FVI) in the common carotid artery (CCA) of AIS patients and healthy controls. Additionally, GSUS was employed to measure carotid intima-media-thickness (cIMT), detect plaques, and quantify total calcification surface. Oscillometry was utilized to evaluate aortic stiffness by carotid-femoral-pulse-wave-velocity (cfPWV). Results 31 patients with AIS and 62-matched (1:2) healthy controls were recruited. AIS-patients exhibited higher CCA-PI (1.89 ± 0.46 vs 1.59 ± 0.32, p= 0.024) and peak-systolic-velocity (80.15 cm/s vs 64.95 cm/s, p= 0.003), compared with controls. Moreover, AIS patients not receiving biologic therapy demonstrated significantly higher cfPWV (6.99 ± 1.71 m/s vs 5.86 ± 0.81 m/s, p= 0.001). cfPWV and cIMT were predicted by age (cfPWV: rho = 0.573; p 0.001, cIMT: rho = 0.675; p= 0.002), systolic-arterial-pressure (SAP) (cfPWV: r = 0.464; p= 0.009, cIMT: rho = 0.514, p= 0.029) and lymphadenopathy (cfPWV: eta = 0.373, p= 0.039). PI associated with nicotine (rho = 0.691, p= 0.008), and FVI (inversely) with SAP (rho=-0.522, p= 0.026). Conclusion In the first CV surrogate marker study in AIS combining oscillometry and arterial US, patients exhibited increased carotid pulsatility and altered flow dynamics vs controls. Aortic stiffness was lower in patients receiving biologics and mainly predicted by traditional CV factors and lymphadenopathy. Angiopathy markers may reveal significant vascular abnormalities in AIS patients, improving CV-screening and risk classification.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Triantafyllias et al. (2026) studied this question.

synapsesocial.com/papers/6966f2f013bf7a6f02c00479https://doi.org/10.1093/rheumatology/keag017
Ask AI
Helpful
Bookmark
Share
View Full Paper